Monark,
Based on their initial ann as CGV they estimated their netback at $45 based on a $80 POO. This was later corrected to $56.45 in a presentation last year (29 Jul 13).
Now my fault for using netback as the term. I will re-phrase that to earning per barrel after royalties etc as I explained. However I have still deducted these production costs from my figures to arrive at my estimates, so am reasonably confident with the numbers.
I disagree with your estimated numbers, and without any workings out they appear dubious to me.
As for shutting in A4, what are you basing that on? It is still a producing asset. I intend for this thread to discuss facts, so lets attempt to stick to that.
Cheers.
- Forums
- ASX - By Stock
- ETR
- CTR Fundamentals
CTR Fundamentals, page-3
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ETR (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.88M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
ETR (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online